MRMD
MARIMED INC.Company Information
- Company Name
- MARIMED INC.
- CIK
- CIK0001522767
- Category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Ticker: Exchange
- MRMD: OTC
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2833
- SIC Description
- Medicinal Chemicals & Botanical Products
- Ticker
- MRMD
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-05-22
- Last sale
- 2024-04-29
- Shares purchased (TTM)
- 145,455
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 645,200
- Shares outstanding
- 399,597,000
- Ownership
- 0.16%
Earnings Market Reaction
- Filing date
- 2026-08-13
- Price on filing date
- —
- 1-month reaction
- 23.08%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash And Cash Equivalents At Carrying Value | 8 | 8 | 9 | 7 | 6 | 7 | 7 | 10 | 10 | 15 | 15 | 13 | ||||||
| Accounts Receivable Net Current | 9 | 9 | 9 | 8 | 8 | 9 | 9 | 7 | 8 | 6 | 7 | 6 | ||||||
| Inventory Net | 37 | 39 | 37 | 40 | 39 | 38 | 33 | 35 | 31 | 29 | 25 | 24 | ||||||
| Deferred Rent Receivables Net | - | - | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Notes And Loans Receivable Net Current | 0 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Short Term Investments | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Receivables Net Current | - | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | ||||||
| Other Assets Current | 4 | 3 | 4 | 5 | 4 | 4 | 3 | 4 | 3 | 3 | 4 | 6 | ||||||
| Assets Current | 58 | 61 | 59 | 60 | 57 | 58 | 54 | 57 | 53 | 55 | 51 | 51 | ||||||
| Property Plant And Equipment Net | 86 | 88 | 89 | 91 | 93 | 94 | 94 | 95 | 94 | 91 | 89 | 85 | ||||||
| Finite Lived Intangible Assets Net | 16 | 16 | 17 | 18 | 21 | 22 | 19 | 20 | 20 | 13 | 17 | 18 | ||||||
| Goodwill | 24 | 24 | 24 | 23 | 20 | 19 | 16 | 16 | 16 | 16 | 12 | 12 | ||||||
| Notes And Loans Receivable Net Noncurrent | 1 | - | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||||||
| Operating Lease Right Of Use Asset | 8 | 8 | 8 | 8 | 8 | 9 | 9 | 9 | 9 | 9 | 10 | 10 | ||||||
| Long Term Investments | - | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Finance Lease Right Of Use Asset | 3 | 3 | 4 | 5 | 4 | 4 | 4 | 4 | 4 | 4 | 3 | 3 | ||||||
| Other Assets Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 11 | 11 | 11 | 13 | 13 | 12 | ||||||
| Assets | 197 | 201 | 203 | 206 | 204 | 208 | 207 | 213 | 209 | 201 | 196 | 191 | ||||||
Liabilities Current | ||||||||||||||||||
| Secured Debt Current | - | - | - | - | - | - | - | - | - | - | - | 4 | ||||||
| Notes Payable Current | 3 | 3 | 3 | 2 | 3 | 5 | 5 | 4 | 4 | 1 | 1 | - | ||||||
| Accounts Payable Current | 13 | 15 | 15 | 11 | 11 | 14 | 13 | 13 | 12 | 10 | 9 | 8 | ||||||
| Accrued Liabilities Current | 10 | 10 | 10 | 9 | 7 | 8 | 4 | 6 | 5 | 5 | 4 | 5 | ||||||
| Contract With Customer Liability Current | 2 | 1 | 1 | 2 | - | - | 1 | - | - | - | - | - | ||||||
| Accrued Income Taxes Current | 32 | 30 | 27 | 28 | 25 | 25 | 22 | 17 | 16 | 16 | 14 | 14 | ||||||
| Operating Lease Liability Current | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | ||||||
| Finance Lease Liability Current | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 | 1 | 1 | 1 | ||||||
| Liabilities Current | 64 | 64 | 59 | 57 | 51 | 55 | 50 | 45 | 41 | 35 | 31 | 35 | ||||||
| Secured Long Term Debt | - | - | - | - | - | - | - | - | - | - | - | 19 | ||||||
| Operating Lease Liability Noncurrent | 6 | 6 | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | ||||||
| Finance Lease Liability Noncurrent | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | ||||||
| Other Liabilities Noncurrent | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Liabilities | 147 | 148 | 138 | 137 | 131 | 134 | 129 | 126 | 121 | 114 | 107 | 92 | ||||||
Temporary Equity | ||||||||||||||||||
| Temporary Equity Carrying Amount Attributable To Parent | 7 | 7 | 15 | 15 | 15 | 15 | 19 | 19 | 19 | 19 | 19 | 19 | ||||||
Stockholders Equity | ||||||||||||||||||
| Preferred Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 180 | 180 | 179 | 179 | 179 | 178 | 173 | 173 | 173 | 171 | 171 | 171 | ||||||
| Retained Earnings Accumulated Deficit | -135 | -132 | -128 | -123 | -119 | -118 | -113 | -104 | -103 | -101 | -100 | -90 | ||||||
| Minority Interest | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | -2 | ||||||
| Stockholders Equity | 43 | 47 | 50 | 54 | 57 | 58 | 59 | 67 | 69 | 69 | 70 | 80 | ||||||
| Common Stock Shares Subscriptions | - | - | - | - | - | - | - | - | - | 0 | 0 | 0 | ||||||
| Liabilities And Stockholders Equity | 197 | 201 | 203 | 206 | 204 | 208 | 207 | 213 | 209 | 201 | 196 | 191 | ||||||
| Series B Convertible Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Series C Convertible Preferred Stock | - | - | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| New Series B Convertible Preferred Stock | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Allowance For Doubtful Accounts Receivable | 1 | 0 | - | 0 | 0 | 0 | - | 0 | 1 | 1 | - | 1 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Preferred Stock Shares Authorized | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | 33 | ||||||
| Preferred Stock Shares Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||
| Common Stock Shares Authorized | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | 700 | ||||||
| Common Stock Shares Issued | 401 | 399 | 397 | 394 | 392 | 389 | 381 | 381 | 380 | 375 | 375 | 376 | ||||||
| Shares Outstanding | 401 | 399 | 397 | 394 | 392 | 389 | 381 | 381 | 380 | 375 | 375 | 376 | ||||||
| Common Stock Shares Subscribed But Unissued | - | - | - | - | - | - | - | - | - | - | 0 | - | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialMARIMED INC. (MRMD) — SEC Financial Statements & Analysis
MARIMED INC. (MRMD) is a medicinal chemicals & botanical products company, incorporated in DE. MARIMED INC. trades on OTC as: MRMD. MARIMED INC. (MRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13. Based on that filing, MARIMED INC. carries a market cap of $27.97M, a P/E ratio of -1.88x, a P/B ratio of 0.65x, a P/S ratio of 0.17x, an enterprise value of $26.31M, and an EV/EBITDA multiple of 4.18x. On profitability, it posts a gross margin of 35.63%, an operating margin of -1.45%, a net margin of -9.10%, a Return on Equity (ROE) of -29.76%, a Return on Assets (ROA) of -7.42%, and a Return on Invested Capital (ROIC) of -4.50%. Per share, it reports EPS of $-0.04, diluted EPS of $-0.04, free cash flow per share of $0.02, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of 4.51% year-over-year, net income growth of -9.30% year-over-year, and EPS growth of -11.50% year-over-year. On the balance sheet, it maintains a current ratio of 0.92x, a quick ratio of 0.34x, working capital of $-5.32M, a debt-to-equity ratio of 3.40x, a debt ratio of 0.75, an interest coverage ratio of -0.30x, free cash flow of $8.01M (TTM), and net debt of $-1.67M. Figures sourced from SEC EDGAR.
- Market Cap
- $27.97M
- P/E TTM
- -1.88x
- EPS TTM
- $-0.04
- P/B TTM
- 0.65x
- ROE TTM
- -29.76%
- ROA TTM
- -7.42%
- Debt To Equity
- 3.40x
- Free Cash Flow TTM
- $8.01M
- Net Revenue TTM Growth 1Y
- 4.51%
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is MARIMED INC. in?
MARIMED INC. (MRMD) operates in the Medicinal Chemicals & Botanical Products industry.
What exchange does MRMD trade on?
MARIMED INC. (MRMD) trades on the OTC.
Where is MARIMED INC. incorporated?
MARIMED INC. is incorporated in DE.
When was MARIMED INC. (MRMD)'s most recent SEC filing?
MARIMED INC. (MRMD)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-13.
What is MRMD's market cap?
MARIMED INC. (MRMD) has a market capitalization of $27.97M as of 2026-06-30.
What is MRMD's EPS (earnings per share)?
MARIMED INC. (MRMD)'s trailing twelve month EPS is $-0.04 as of 2026-06-30.
What is MRMD's ROE (return on equity)?
MARIMED INC. (MRMD)'s trailing twelve month Return on Equity (ROE) is -29.76% as of 2026-06-30.
What is MRMD's ROA (return on assets)?
MARIMED INC. (MRMD)'s trailing twelve month Return on Assets (ROA) is -7.42% as of 2026-06-30.
What is MRMD's ROIC (return on invested capital)?
MARIMED INC. (MRMD)'s trailing twelve month Return on Invested Capital (ROIC) is -4.50% as of 2026-06-30.
What is MRMD's EV/EBITDA?
MARIMED INC. (MRMD)'s trailing twelve month EV/EBITDA is 4.18x as of 2026-06-30.